Preemptive therapy versus universal prophylaxis: Time for reconciliation?

被引：2
|
作者：
Kampouri, Eleftheria [1 ]
Manuel, Oriol [2 ,3 ,4 ,5 ]
机构：
[1] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[2] Lausanne Univ Hosp, Infect Dis Serv & Transplantat Ctr, Lausanne, Switzerland
[3] Univ Lausanne, Lausanne, Switzerland
[4] Lausanne Univ Hosp, Infect Dis Serv & Transplantat Ctr, BH10-549,Bugnon 46, CH-1011 Lausanne, Switzerland
[5] Univ Lausanne, BH10-549,Bugnon 46, CH-1011 Lausanne, Switzerland
来源：
TRANSPLANT INFECTIOUS DISEASE | 2023年 / 25卷 / 02期
关键词：
ONSET CYTOMEGALOVIRUS DISEASE; LIVER-TRANSPLANT RECIPIENTS; ANTIVIRAL PROPHYLAXIS;
D O I：
10.1111/tid.14014
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparison of CMV prophylaxis and preemptive therapy in liver and kidney transplant recipients.
    Taber, DJ
    Dupuis, RE
    Hollar, KD
    Meehan, A
    Rodegast, B
    Salm, J
    Zacks, S
    Shrestha, R
    Gerber, D
    Johnson, MW
    TRANSPLANTATION, 2000, 69 (08) : S181 - S181
  • [42] The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy
    Marty, FM
    Rubin, RH
    TRANSPLANT INTERNATIONAL, 2006, 19 (01) : 2 - 11
  • [43] Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis
    Bacigalupo, Andrea
    CURRENT OPINION IN HEMATOLOGY, 2025, 32 (02) : 104 - 108
  • [44] Empirical versus preemptive antimycotic therapy in terms of outcome benefit
    S Milanov
    VT Todorova
    G Georgiev
    M Milanov
    Critical Care, 17 (Suppl 2):
  • [45] Reconciliation policies: working policies versus time policies
    Borras, Vicent
    Torns, Teresa
    Moreno, Sara
    PAPERS-REVISTA DE SOCIOLOGIA, 2007, 83 : 83 - 96
  • [46] Empirical versus Preemptive Antifungal Therapy for Fever during Neutropenia
    Marr, Kieren A.
    Leisenring, Wendy
    Bow, Eric
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (07) : 1138 - 1139
  • [47] Antiviral Prophylaxis Versus Preemptive Therapy to Prevent Cytomegalovirus Infection and Related Death in Liver Transplantation: A Retrospective Study With Propensity Score Matching
    Kim, S. I.
    Kim, C. J.
    Kim, Y. J.
    Son, H.
    Kim, Y. E.
    Kim, M. S.
    Hwang, S.
    Kim, J. I.
    You, Y. K.
    Kim, D. G.
    Kang, M. W.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (03) : 787 - 790
  • [48] Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients
    Liu, Amy W.
    Jutivorakool, Kamonwan
    Fisher, Cynthia E.
    Rakita, Robert M.
    Reyes, Jorge D.
    Bhattacharya, Renuka B.
    Jerome, Keith R.
    Limaye, Ajit P.
    TRANSPLANTATION, 2018, 102 (04) : 632 - 639
  • [49] Abolition of cytomegalovirus disease with aggressive prophylaxis and preemptive therapy in mismatched lung transplant recipients
    Hopkins, P. M.
    Kermeen, F.
    Dunning, J.
    McNeil, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S174 - S174
  • [50] Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
    Witzke, Oliver
    Hauser, Ingeborg A.
    Bartels, Michael
    Wolf, Gunter
    Wolters, Heiner
    Nitschke, Martin
    TRANSPLANTATION, 2012, 93 (01) : 61 - 68
12345